U.S. Stem Cell, Inc. (USRM)
Develops stem cell therapies to treat heart damage and regenerative conditions.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
USRM trades at $0.0001, sitting above both its 50- and 200-day moving averages. Analyst coverage appears minimal or absent for this micro-cap stock. The extremely low price and minimal trading activity are typical characteristics of penny stocks.
What’s behind the score
Price trendAbove its 50- & 200-day averages
Market cap
$64,150
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—